Agios Pharmaceuticals
AGIO
#4998
Rank
S$2.51 B
Marketcap
S$42.07
Share price
-3.77%
Change (1 day)
-12.90%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: S$2.51 Billion

As of September 2026 Agios Pharmaceuticals has a market cap of S$2.51 Billion. This makes Agios Pharmaceuticals the world's 4998th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.51 B19.73%
2025S$2.09 B-18.98%
2024S$2.58 B57.5%
2023S$1.64 B-20.52%
2022S$2.06 B-14.29%
2021S$2.41 B-39.21%
2020S$3.97 B-9.84%
2019S$4.40 B20.07%
2018S$3.66 B-1.63%
2017S$3.72 B46.91%
2016S$2.53 B-26.7%
2015S$3.46 B-36.97%
2014S$5.49 B480.1%
2013S$0.94 B

End of Day market cap according to different sources

On Sep 24th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

S$2.51 Billion
by Nasdaq info icon info icon
S$2.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$207.07 B 8,143.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.347 T 53,534.57%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$127.16 B 4,962.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
S$2.27 B-9.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$18.36 B 631.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$15.18 B 504.61%๐Ÿ‡บ๐Ÿ‡ธ USA